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Abstract
For many complex diseases, prognosis is of essential importance. It has been shown that, be-
yond the main effects of genetic (G) and environmental (E) risk factors, the gene-environment
(G×E) interactions also play a critical role. In practice, the prognosis outcome data can be
contaminated, and most of the existing methods are not robust to data contamination. In the
literature, it has been shown that even a single contaminated observation can lead to severely
biased model estimation. In this study, we describe prognosis using an accelerated failure time
(AFT) model. An exponential squared loss is proposed to accommodate possible data contam-
ination. A penalization approach is adopted for regularized estimation and marker selection.
The proposed method is realized using an effective coordinate descent (CD) and minorization
maximization (MM) algorithm. Simulation shows that without contamination, the proposed
method has performance comparable to or better than the unrobust alternative. With contami-
nation, it outperforms the unrobust alternative and, under certain scenarios, can be superior to
the robust method based on quantile regression. The proposed method is applied to the analysis
of TCGA (The Cancer Genome Atlas) lung cancer data. It identifies interactions different from
those using the alternatives. The identified marker have important implications and satisfactory
stability.
Keywords: Gene-environment interaction, prognosis, robustness, exponential squared loss, penal-
ization, marker identification.
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Introduction
For many complex diseases such as cancer, diabetes, and cardiovascular diseases, prognosis is of
essential interest. In the omics era, profiling studies have been extensively conducted, searching for
genetic markers associated with prognosis. It has been suggested that, beyond the main effects of
genetic (G) and environmental (E) risk factors, the gene-environment (G×E) interactions also have
important implications. Multiple statistical methods have been developed for G×E interaction
analysis. For reviews, refer to Caspi & Moffitt (2006), Cordell (2009), Thomas (2010), and others.
Denote T as the prognosis time of interest, X = (X1, . . . ,Xq) as the q environmental/clinical
variables, and Z = (Z1, . . . , Zp) as the p genetic variables. Assume n independent subjects.
Regression-based interaction analysis, with its broad applicability, has been extensively adopted
and proceeds as follows. (a) For gene j(= 1, . . . , p), consider the model T ∼ φ(αj,0+
∑q
k=1Xkαj,k+
Zjβj+Zj
∑q
k=1Xkγj,k), where φ(·) is the known link function (for example, the Cox or exponential
model), and αj,0, αj,k, βj , γj,k are the unknown regression coefficients. As usually q << n, this is a
low-dimensional model and can be fitted using standard, usually likelihood-based, techniques and
software. Denote pj,k as the p-value for γj,k. (b) With {pj,k : j = 1, . . . , p; k = 1, . . . , q}, conduct
multiple comparison adjustment using the Bonferroini or FDR (false discovery rate) approach, and
identify important interactions.
A limitation of the above approach is a lack of robustness properties. Usually it is assumed that
all subjects satisfy the same prognosis models. In practice, most genetic studies cannot afford to
conduct strict subject selection. Seemingly homogeneous subjects can have different disease sub-
types (Haibe-Kains et al., 2012) and different survival patterns (Burgess, 2011). Cause of death can
be misclassified, leading to contamination in disease-specific survival (Fall et al., 2008). The sur-
vival times extracted frommedical records are not always reliable (Bowman (2011), Rampatige et al.
(2013)). With unrobust for example likelihood-based estimation, even a single contaminated obser-
vation can result in severely biased estimates (Huber & Ronchetti, 2009), which can lead to false
marker identification. Another limitation is that, significance level-based identification, although
asymptotically valid, may generate unreliable results when the sample sizes are small to moderate,
as in typical profiling studies. A recent study suggests that regularized estimation can lead to more
reliable estimation and hence more accurate marker identification (Shi et al., 2014).
With low-dimensional biomedical data, robust statistical methods have demonstrated great
power. As suggested in a recent review by Wu & Ma (2014), with genetic data, the development is
limited and unsystematic and has been mostly on the analysis of main effects but not interactions.
In the literature, relevant studies include Gui et al. (2011), which identifies important interactions
using the multifactor dimensionality reduction (MDR) technique. However, this method is limited
to categorial data (such as SNPs) and not broadly applicable. Shi et al. (2014) developed a rank-
based method, which is robust to model mis-specification but not data contamination. The most
relevant study is perhaps Wang et al. (2015), which developed a quantile-regression based method.
With that method, the quantile needs to be specified, which is not a trivial task in practical data
analysis. The objective function is not differentiable, causing difficulty in estimation. In addition,
as to be shown in this study, its numerical performance can be less satisfactory under many data
settings. With low-dimensional data, it has been shown that no robust method dominates the
others. It is thus prudent to develop alternative robust methods.
Consider prognosis data with both G and E measurements. The goal is to develop a new method
for identifying important G×E interactions. Significantly advancing from the existing studies, the
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proposed method is robust to contamination in the prognosis data. In addition, our simulation
suggests that, under certain scenarios, its numerical performance is better than the quantile regres-
sion analysis, which is perhaps the most popular robust method for genetic data (Wu & Ma, 2014).
A penalization approach is adopted for marker identification, which differs from the significance
level-based approach and can have better numerical performance when the sample size is small to
moderate.
Robust identification of interactions
Data and model settings
In the literature, there are multiple prognosis models. In this study, we consider the accelerated
failure time (AFT) model, which has been adopted in Shi et al. (2014), Liu et al. (2013), and many
others. Compared to alternatives such as the Cox model, the AFT model can be preferred because
of its more intuitive interpretations and lower computational cost, which are especially desirable
with high-dimensional genetic data. With a slight abuse of notation, still T to denote the logarithm
of prognosis time. For gene j, the AFT model assumes that
T = αj,0 +
q∑
k=1
Xkαj,k + Zjβj + Zj
q∑
k=1
Xkγj,k + ǫ,
where ǫ is the random error.
Assume n independent observations. Consider the scenario where a small subset of the random
errors are contaminated, leading to contamination in the prognosis times. In a typical profiling
study, q << n, while p can be comparable to or much larger than n. For subject i, denote Ci
as the logarithm of censoring time and xi and zi as the observed X and Z values, respectively.
Under right censoring, we observe (yi = min(Ti, Ci), δi = I(Ti ≤ Ci),xi, zi). Further denote ui,j =
(1,x′i, zi,j, zi,jxi,1, . . . , zi,jxi,q)
′, ζj = (αj,0, αj,1, . . . , αj,q, βj , γj,1, . . . , γj,q)
′, andUj = (u1,j , . . . ,un,j)
′
which is a n × (2q + 2) matrix. For gene j and subject i, the AFT model can now be written as
Ti = u
⊤
i,jζj + ǫi,j. Without loss of generality, assume that the data {(yi, δi,xi, zi), i = 1, . . . , n} have
been sorted according to yi’s from the smallest to the largest.
Penalized robust identification
A penalized marker identification method is defined by its loss function and penalty, which are
defined separately as follows.
Loss function Before defining the robust loss function, we take one step back and consider the
scenario with no data contamination. When the distribution of ǫ is not specified, likelihood-
based estimation cannot be adopted. A popular approach is the weighted least squared estimation
proposed in Stute (1993) and proceeds as follows. First compute the Kaplan-Meier weights as
ω1 =
δ1
n
, ωi =
δi
n− i+ 1
i−1∏
j=1
(
n− j
n− j + 1)
δj , i = 2, · · · , n.
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For gene j(= 1, . . . , p), the weighted least squared objective function is defined as
n∑
i=1
ωi(yi − u⊤i,jζj)2, (1)
This loss function has the following properties. With a simple linear regression model, the most
commonly adopted loss function is the least squared one. Here to accommodate censoring, a weight
function is imposed to re-weigh different observations according to their observed times and event
status. When there is no censoring, ωi = 1/n. With the quadratic form, the loss function is not
robust to data contamination. If subject i is not censored, then ωi 6= 0, and an arbitrarily large
yi results in arbitrarily large estimates. Biased estimation can happen with data contamination,
which may lead to false marker identification.
To accommodate data contamination, for gene j(= 1, . . . , p), we propose the exponential squared
loss function
Qθ(ζj |y,Uj ,ω) =
n∑
i=1
ωi exp(−(yi − u⊤i,jζj)2/θ). (2)
y and ω denote the vectors composed of yi’s and ωi’s, respectively. θ > 0 is a tuning parame-
ter. The rationale of this approach is as follows. For contaminated subjects with yis deviate from
u⊤i,jζjs (predicted values from the model), (yi−u⊤i,jζj)2s have large values. The exponential function
down-weighs such contaminated observations. The degree of down-weighing is adjusted by θ: with
θ getting smaller, contaminated observations have smaller influence. To accommodate censoring,
ωi’s are imposed in a similar manner as the original Stute’s approach. For low-dimensional linear
regression model without censoring, the exponential squared loss has been examined in Wang et al.
(2013). Different from the existing studies, here we consider the more challenging high-dimensional
genetic data especially interactions. In addition, the Kaplan-Meier weights are introduced to ac-
commodate censoring. As to be shown in Appendix, such differences lead to significant differences
in the statistical development.
Penalized estimation For gene j(= 1, . . . , p), we propose the penalized objective function
Lλ,θ(ζj |y,Uj ,ω) = Qθ(ζj |y,Uj ,ω)− λ||ζj ||1. (3)
λ > 0 is the data-dependent tuning parameter, and ||·||1 is the ℓ1 norm. Denote ζ˜j as the maximizer
of Lλ,θ(ζj |y,Uj ,ω). Interactions (and main effects) corresponding to the nonzero components of
ζ˜j are identified as important.
The strategy of using penalization for identifying important interactions has been adopted
in Shi et al. (2014) and other studies. Here a Lasso penalty is imposed, which is the most commonly
adopted penalty. λ controls the degree of sparsity and number of identified interactions. We impose
the same λ to all genes to ensure comparability.
Multiple penalties can take place of Lasso. In some recent studies such as Bien et al. (2013)
and Liu et al. (2013), penalties have been developed to respect the “main effects, interactions”
hierarchy, which reinforces that the main effects corresponding to the identified interactions must
be identified. In a large number of studies (Zimmermann et al. (2011), Caspi & Moffitt (2006)),
it has been observed that genes can have important G×E interactions but no main effects. In
addition, if the hierarchy has to be reinforced, we can identify the important interactions first, and
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then add back the corresponding main effects. Computationally, Lasso is much simpler than the
existing alternatives. Our limited experience suggests that with the complex robust loss function,
complex penalties have a considerable probability of running into convergence problems. With the
above considerations, the Lasso penalty is adopted here.
Consistency properties A significant advantage of the proposed method is that it has the much
deserved consistency properties under the ultrahigh dimensional setting. For many of the existing
interaction analysis methods, there is a lack of theoretical development. The rigorously established
consistency properties provide a solid statistical ground for the proposed method. Details are
provided in Appendix.
Computation
We propose a coordinate-wise updating procedure to compute the solution to (3). For low-
dimensional data under simpler settings, an iterative approach is suggested in Wang et al. (2013)
to select the robust tuning parameter θ. However, under the present high-dimensional settings and
with the coordinate-wise updating procedure, such an approach is computationally infeasible. Al-
ternatively, for each (λ, θ) pair, we compute the solution to each marginal model. This way, we can
obtain a solution surface over the two-dimensional tuning parameter grid. Then a prediction error
based method such as cross-validation can be used to select the robust and penalization tuning
parameters. Computation is conducted for each gene separately and can be realized in a highly
parallel manner to reduce computer time.
Consider gene j(= 1, . . . , p). Let ri(ζj) = yi − u⊤i,jζj . The first and second order derivatives of
Q(ζj) areQ˙k(ζj) =
∂Q(ζj)
∂ζj,k
= 2
∑n
i=1 ωiu(i,j)kri(ζj) exp(−r2i (ζj)/θ)/θ,
Q¨kl(ζj) =
∂2Q(ζj)
∂ζj,k∂ζj,l
= 2
∑n
i=1 ωiu(i,j)ku(i,j)l exp(−r2i (ζj)/θ)(2r2i (ζj)/θ − 1)/θ.
(4)
For a ζmj that is in a small neighborhood of ζj , Q(ζj) in (3) can be locally approximated by
Q(ζj) ≈ Q(ζmj ) + Q˙(ζmj )⊤(ζj − ζmj ) +
1
2
(ζj − ζmj )⊤Q¨(ζmj )(ζj − ζmj ). (5)
Replacing Q(ζj) in (3) with this approximation and taking the first order derivative of L(ζj) with
respect to the kth element ζj,k give us
ζm+1j,k = ζ
m
j,k − Q¨−1kk (ζmj )Q˙k(ζmj ) + Q¨−1kk (ζmj )λ. (6)
Note that when 2r2i (ζj)/θ > 1, Q¨kk(ζj) ≥ 0. Then (3) can be maximized at infinity, and the
algorithm may fail to converge. To avoid this problem, notice that
Q¨kk(ζj) ≥ −2
n∑
i=1
ωiu
2
(i,j)k
exp(−r2i (ζj)/θ)/θ
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for ωi ≥ 0. The right hand side is always non-positive. We re-define
Q¨kk(ζj) ≡ −2
n∑
i=1
ωiu
2
(i,j)k
exp(−r2i (ζj)/θ)/θ,
and use the minorization-maximization (MM) algorithm to ensure convergence. The algorithm that
combines the coordinate descent and MM algorithm is summarized in Algorithm 1.
Algorithm 1: The coordinate descent MM algorithm for marginal model j
input : y,ω,Uj , and tuning parameters λ and θ.
output: the maximizer ζ˜j defined in (3).
initialization: let m = 0, ζ0j = 0. Normalize y and Uj such that
∑n
i=1 ωiyi = 0,∑n
i=1 ωiu(i,j)k = 0 and
∑n
i=1 ωiu
2
(i,j)k
= n for k = 1, . . . , 2q + 2.;
repeat
m0 = m;
for k = 1, 2, . . . , 2q + 2 do
repeat
ζm+1j,k = ζ
m
j,k − Q¨−1kk (ζmj )Q˙k(ζmj ) + Q¨−1kk (ζmj )λ;
ζm+1j,l = ζ
m
j,l for l = 1, 2, . . . , 2q + 2, l 6= k;
m = m+ 1;
until |ζmj,k − ζm−1j,k | ≤ a predefined thresholding value. In our numerical study, we set
the thresholding =10−3;
end
until ||ζm0j − ζmj ||2 ≤ a predefined thresholding value;
return ζmj as the maximizer.
As mentioned above, we search over a two-dimensional grid of (λ, θ) for the optimal. The
range of λ is determined as follows. First, its upper bound λmax is selected such that ζ˜j = 0 for
j = 1, . . . , p. With the unrobust weighted least squared loss, λmax = max
p
j=1{||U⊤j Wy||∞} where
W is the diagonal matrix composed of ωis. With the proposed robust method, the derivatives in (4)
can be viewed as a weighted sum of u(i,j)kri(ζj)s. Because the weight for each subject changes with
ζj , the previously defined λmax may not guarantee that ζ˜j = 0 for j. After some trials, we find that
λmax = 20max
p
j=1{||U⊤j Wy||∞} is in general a safe upper bound for λ. The lower bound is chosen
as λmin = λmax/1000. The range of θ depends on the degree of contamination in data, which is not
known in practice. In our numerical studies, we find that the estimator is not very sensitive to the
value of θ. For cautions, we choose a relatively wide range for θ. Specifically, after centralization,
we choose θ ∈ (minni=1 y2i /100,maxni=1 y2i × 100).
With the quadratic approximation and minorization, optimization in (3) is non-convex. There-
fore, there is a risk of converging to local maximums. Thus when trying to solve the estimate at a
new (λ, θ) point, instead of using ζ0j = 0 as the starting value, we use the estimate at a neighboring
(λ, θ) point as the warm starting value. This modification speeds up the computation and also
improves the convergence property.
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Simulation
In simulation, we set n = 300, q = 3, and p = 500, 1000. There are a total of 18 nonzero effects:
3 main effects of E factors, 5 main effects of G factors, and 10 interactions. The positions of
nonzero main G effects and interactions are uniformly placed. The nonzero regression coefficients
are randomly generated from uniform(0.5, 1.5). The E and G factors are generated from multi-
variate normal distributions with marginal means zero, marginal variances one, and the following
variance matrix structures: Independent, AR(0.2), AR(0.8), Band(0.3), and Band(0.6). Under
the AR(ρ) correlation structure, for the ith and jth factors, corr = ρ|i−j|. Under the Band(ρ)
correlation structure, for the ith and jth factors, corr = ρI(|i − j| ≤ 2), where I(·) is the in-
dicator function. Under each correlation scenario, consider seven different distributions for the
random error ǫ: N(0,1), 0.95N(0,1)+0.05Cauchy, 0.85N(0,1)+0.15Cauchy, 0.7N(0,1)+0.3Cauchy,
0.95N(0,1)+0.05t(3), 0.85N(0,1)+0.15t(3), and 0.7N(0,1)+0.3t(3). That is, we consider the scenar-
ios with no contamination and three different levels of contamination. Two contamination distri-
butions are considered with different thickness of tails. The log event times are generated from
the AFT models. The censoring times are generated independently from exponential distributions.
The parameters are adjusted so that the censoring rates are about 25%.
Beyond the proposed method (referred to as “Robust”), we also consider the following three
alternatives: (a) the “Unrobust” method, which adopts the weighted least squared loss function and
applies the Lasso penalization for selecting important effects; (b) the “Stute” method, which adopts
the weighted least squared loss function, does not apply any penalization, and uses the significance
level (p-value) as the criterion for quantifying the importance of effects; and (c) the “Quantile”
method, which adopts the quantile regression-based robust loss function and applies the Lasso
penalization for selecting important effects. The Unrobust and Stute methods, as the proposed, are
built on the weighted least squared estimation. Comparing with them can establish the advantage of
robust loss and penalization-based identification, respectively. The Quantile method is also robust
and has been recently developed. Comparing with it can establish the advantage of the weighted
exponential squared loss. We acknowledge that multiple methods are potentially applicable to the
simulated data. The three alternatives have frameworks closest to that of the proposed.
With the Robust, Unrobust, and Quantile methods, the numbers of selected interactions de-
pend on the tuning parameter values. With the Stute method, the number depends on the p-value
cutoff. To eliminate the effect of tuning parameter selection on identification, we examine a se-
quence of tuning parameter values, evaluate identification performance at each value, and use the
ROC (receiver operating characteristics) curve to evaluate the interaction identification accuracy
of different methods. A representative ROC plot is shown in Figure 1. In this plot, the proposed
method has the dominatingly better accuracy.
Summary AUCs based on 100 replicates are shown in Tables 1 (p = 500) and 2 (p = 1000).
When there is no contamination, performance of the proposed method is comparable to or slightly
worse than that of the unrobust method. For example with p = 500 and the independence corre-
lation structure, the robust and unrobust methods have mean AUCs 0.861 and 0.889, respectively.
And with the AR(0.2) correlation, they have mean AUCs 0.901 and 0.881, respectively. With con-
tamination, the robust method outperforms the unrobust method. For example with p = 500, the
AR(0.2) correlation structure, and 0.7N(0,1)+0.3Cauchy error, the robust and unrobust methods
have mean AUCs 0.886 and 0.751, respectively. Under all simulation scenarios, the Stute method,
which adopts the robust loss function but significance level-based identification, has inferior iden-
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tification accuracy. As has been suggested in the literature, with a moderate sample size, the
unregularized estimates can be less reliable, leading to inaccurate identification. When comparing
the proposed method with the quantile regression-based, we see that under the majority of the
settings, the proposed method has superior performance. For example with p = 500, AR(0.2) cor-
relation, and 0.85N(0,1)+0.15Cauchy error, the proposed method and Quantile have mean AUCs
0.892 and 0.842, respectively. However, under a small number of settings, the Quantile method ex-
cels. For example with p = 500, AR(0.8) correlation, and 0.7N(0,1)+0.3t(3) error, the two methods
have mean AUCs 0.863 and 0.933, respectively. Such observations are also reasonable. No robust
approach is expected to be able to dominate all others. The proposed method outperforms the
quantile regression-based under most scenarios and provides a useful alternative.
Analysis of the lung squamous cell carcinoma data
Lung squamous cell carcinoma is the second most common lung cancer and causes around 400,000
deaths each year worldwide (The Cancer Genome Atlas Research Network, 2012). Profiling studies
have been extensively conducted searching for its prognostic factors. In this section, we analyze the
TCGA (The Cancer Genome Atlas) data on the prognosis of lung squamous cell carcinoma. The
TCGA data were recently collected and published by NCI and have a high quality. The dataset
we analyze was downloaded in April of 2015.
The prognosis outcome of interest is overall survival. Multiple environmental and clinical vari-
ables are available for analysis. We first remove variables with a low quality of measurements (for
example with a high missing rate). We then select the following variables for analysis: age, gen-
der (female is coded as baseline), smoking pack years, and smoking status (non-smoker, reformed
smoker for more than 15 years, reformed smoker for less than or equal to 15 years, current smoker;
coded as 0, 1, 2 and 3). These variables have been suggested in the literature (Miller et al. (2004)
and Nakachi et al. (1991)). A total of 422 samples have clinical and environmental measurements
available.
For the genetic part, we analyze gene expression data. A total of 18,969 measurements are
available for 502 samples. When matching the clinical/environmental data with genetic data,
complete data are available for 404 samples. Among them, 129 died during following. The median
followup was 30 months. 275 were censored, and the median followup was 18 months.
The tuning parameter can be chosen using data-driven methods for example cross validation.
However, we note that the commonly used methods are mostly based on the notion of prediction.
With a large number of marginal models, the goal is to identify markers top-ranked in a marginal
sense, not prediction. Thus, following published studies, we vary the tuning so that a prefixed
number of interactions are selected. In Table 3, we provide results on the 33 top-ranked interactions.
Longer or shorter lists of identified interactions are available from the authors. After the interactions
are identified, we refit the marginal models without penalization on the main effects to satisfy the
“main effects, interactions” hierarchy. Beyond the proposed method, we also apply the three
alternatives considered in simulation. Table 4 in Appendix suggests that different methods identify
significantly different genes and interactions. Results under the proposed method are provided in
Table 3. Those under the alternative methods are provided in Appendix.
To assess the stability of our findings, we apply a cross validation-based approach. Specifically,
one sample is removed from data, and the proposed method is applied. This step is repeated over
all samples. For each identified interaction in Table 3, we compute its probability of being identified
in the reduced datasets. It can be seen that three interactions have very small stability measures.
All other interactions have stability measures close to 1. We have also examined those interactions
not identified and found that their stability measures are all close to 0. This analysis suggests a
certain degree of stability of the proposed method.
Literature search suggests that the identified interactions and corresponding genes may have
important implications. Specifically, previous studies (Shi et al., 2014) have suggested that the ma-
jor G×E interactions occur between genes and smoking status. Among the identified gene-smoking
interactions in the current study, the CEBPB (CCAAT/enhancer-binding proteins beta) protein is
a transcription factor that works with other CCAAT/enhancer-binding protein family members in
the regulation of cell cycle progress, differentiation and pro-inflammatory gene expression. CEBPB
has been found to be upregulated by tobacco smoke in both human lung fibroblast (Miglino et al.,
2012) and mice emphysema (Hirama et al., 2007). Another gene that interacts with smoking is
EFNA1 (a.k.a. ephrin-A1). A recent in vitro study found that ephrin-A1 is overexpressed in
tobacco smoke treated bronchial airway epithelial cells compared to control cells (Nasreen et al.,
2014). In addition, the elevated expressions of ephrin-A1 are positively associated with tumor
proliferative capacity in non-small cell lung carcinoma patients (Giaginis et al., 2014). The gene
that shows both a strong main effect and interaction with duration of smoking is TERF1 (telom-
eric repeat binding factor 1). The TERF1 expression levels have been found to be decreased in
lung cancer (Lin et al. (2006), Jian et al. (2009)), as well as other types of cancer in several stud-
ies (Yamada et al. (2002), Miyachi et al. (2002)). It functions as an inhibitor of telomerase and
is identified as a prognostic marker for overall survival in non-small cell lung cancer (Jian et al.,
2009). The molecular mechanism of why and how TERF1 decreases in the process of cancer is not
clear. Our results suggest that smoking can be one of the factors. Other than smoking duration,
we also find that several genes interact with smoking intensity as well. The gene that interacts with
both gender and smoking intensity is KATNB1. KATNB1 encodes protein katanin p80 subunit
B1, which has been found to participate in cytokinesis by interacting with tumor suppressor gene
LAPSER1. The disruption of cytokinesis process may potentially cause genetic instability and
cancer (Sudo & Maru, 2007). In addition to smoking, we find eight genes interact with gender in
Table 3. Among these, STRADB and CA5BP1 draw our attention. STRADB is an important
gene in lung cancer progression and metastasis through the activation of LKB1. LKB1 is essential
for G1 cell cycle arrest, cell polarity and stress, cell detachment and adhesion (Marcus & Zhou,
2010). The STRADB encoded protein also interacts with the X chromosome-linked inhibitor of
apoptosis protein by enhancing its anti-apoptotic activity. In addition, gene CA5BP1 is located on
X chromosome and found to be gender-associated.
Discussion
G×E interactions have important implications for the prognosis of a large number of complex
diseases. In this study, we have developed a novel interaction analysis method. It is robust to
contamination in the prognosis outcome, which is not rare in practice but cannot be accommodated
using most of the existing methods. In addition, we adopt penalization for identifying important
interactions. This strategy differs from the commonly adopted significance level-based identification
and can have better marker identification accuracy. Significantly advancing from most of the
existing interaction studies, the consistency property has been rigorously established under the
ultrahigh dimensional setting, making the proposed method one of the very few with a strong
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theoretical basis. An effective computational algorithm has been developed. In simulation study,
the proposed method is observed to have satisfactory performance. With contamination, robust
methods are needed. Under the majority of the cases, the proposed method outperforms the
quantile regression based method. Thus, it provides a useful alternative to the quantile regression-
based and other existing methods. In the analysis of lung cancer data, the proposed method
identifies meaningful genes and interactions, which differ from those using the alternatives, with
satisfactory stability.
We choose the popular Lasso penalty because of its low computational cost and satisfactory
performance. A limitation of Lasso is that its results may not respect the “main effects, interactions”
hierarchy. However, as shown in Appendix, the proposed method can consistently identify the
important interactions. As demonstrated in data analysis, once the important interactions are
identified, if the hierarchy is desired, the main effects can be added back. With a robust loss
function, the proposed method is computationally more expensive. However, as the computing
can be executed in a highly parallel manner, and with the effective coordinate descent algorithm,
the computer time is very much affordable. A total of 70 scenarios are considered in simulation
and show the satisfactory performance of proposed method. More comprehensive comparisons of
different methods, especially robust methods, have not been conducted in the literature and are of
interest to future studies. Interesting findings are made in the lung cancer prognosis data analysis.
Unfortunately there is still a lack of objective way of determining which set of results is more
sensible. Validation of the findings will be pursued in future studies.
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Table 1: Simulation: AUC×100 (sd) based on 100 replicates, p = 500.
Error Method Independent AR(0.2) AR(0.8) Band(0.3) Band(0.6)
N(0,1) Robust 86.1(7.7) 90.1(6.6) 86.7(6.9) 89.2(5.7) 94.3(5.8)
Unrobust 88.9(6.6) 88.1(5.7) 86.8(6.1) 83.6(6.3) 91.0(8.2)
Stute 65.7(4.4) 63.3(3.3) 61.6(4.6) 64.7(3.5) 61.0(2.3)
Quantile 82.9(3.3) 86.3(1.2) 93.5(2.1) 88.9(2.5) 76.5(5.1)
0.95N(0,1)+ Robust 91.1(7.8) 87.1(6.9) 88.7(5.1) 87.7(6.6) 88.1(6.5)
0.05Cauchy Unrobust 82.8(8.6) 85.9(10) 88.7(8.5) 81.9(12.6) 78.5(10.2)
Stute 68.0(4.7) 60.1(4.6) 70.6(4.8) 64.7(3.5) 73.3(4.7)
Quantile 82.7(3.1) 83.4(3.4) 92.4(2.9) 87.4(2.5) 71.9(3.9)
0.85N(0,1)+ Robust 86.6(8.2) 89.2(7.0) 93.9(6.9) 86.8(6.9) 83.5(5.8)
0.15Cauchy Unrobust 77.1(9.4) 85.0(10.2) 87.1(12.7) 72.8(10.3) 76.2(11.6)
Stute 64.2(6.3) 63.7(5.5) 67.5(6.9) 64.7(3.5) 67.8(6.4)
Quantile 81.9(3.1) 84.2(1.7) 93.6(2.7) 89.4(2.4) 69.1(5.1)
0.7N(0,1)+ Robust 84.8(6.9) 88.6(6.6) 87.9(5.9) 89.2(5.7) 90.1(5.9)
0.3Cauchy Unrobust 71.7(11.8) 75.1(13.3) 77.8(12.8) 80.8(6.5) 86.3(8.2)
Stute 64.5(8.2) 59.4(5.8) 65.7(8.5) 64.7(3.5) 64.4(6.6)
Quantile 80.1(2.7) 85.8(2.3) 92.5(2.4) 88.2(2.9) 68.1(8.3)
0.95N(0,1)+ Robust 80.8(7.3) 89.4(6.1) 93.4(5.0) 69.9(5.4) 88.8(6.7)
0.05t(3) Unrobust 76.7(9.1) 84.7(8.4) 89.6(9.0) 82.1(11.6) 85.4(10.1)
Stute 60.8(4.5) 66.7(4.9) 68.6(5.0) 64.7(3.5) 73.8(4.9)
Quantile 82.6(2.1) 85.4(2.6) 89.7(2.5) 87.8(2.2) 73.4(6.6)
0.85N(0,1)+ Robust 87.5(7.5) 85.6(6.6) 90.6(6.0) 87.9(6.5) 79.8(5.8)
0.15t(3) Unrobust 82.3(11.7) 79.4(10.6) 83.5(11.8) 75.5(13.9) 75.5(12.2)
Stute 67.4(5.4) 61.4(5.1) 68.6(5.0) 64.7(3.5) 68.2(4.4)
Quantile 83.1(3.4) 85.3(3.1) 92.4(1.6) 87.7(3.6) 72.7(4.1)
0.7N(0,1)+ Robust 84.4(7.2) 88.6(6.8) 86.3(6.7) 88.4(5.3) 85.4(5.3)
0.3t(3) Unrobust 71.9(11.7) 71.5(12.3) 76.0(13.1) 80.7(6.4) 80.0(4.8)
Stute 62.3(8.4) 62.0(7.4) 68.6(5.0) 64.7(3.5) 60.6(6.9)
Quantile 79.8(4.1) 83.9(2.6) 93.3(1.9) 87.1(3.1) 68.5(6.3)
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Table 2: Simulation: AUC×100 (sd) based on 100 replicates, p = 1, 000.
Error Method Independent AR(0.2) AR(0.8) Band(0.3) Band(0.6)
N(0,1) Robust 89.2(6.8) 87.4(6.7) 94.0(5.0) 92.8(7.2) 85.4(5.3)
Unrobust 84.4(6.1) 87.9(6.3) 91.7(4.5) 86.8(7.3) 80.0(4.8)
Stute 64.7(6.0) 66.7(4.2) 68.6(5.0) 76.5(4.9) 73.4(4.0)
Quantile 82.4(2.2) 85.1(3.1) 92.8(4.2) 88.7(2.7) 71.1(3.9)
0.95N(0,1)+ Robust 86.0(7.4) 76.4(6.1) 87.4(5.1) 89.3(6.2) 94.5(5.7)
0.05Cauchy Unrobust 82.0(8.9) 83.9(10.6) 88.4(5.5) 80.0(11.6) 91.2(7.2)
Stute 62.2(4.6) 64.6(5.9) 68.6(5.0) 65.4(4.1) 71.5(4.6)
Quantile 82.3(3.4) 85.9(2.3) 90.6(2.1) 88.4(1.9) 70.9(6.6)
0.85N(0,1)+ Robust 85.4(6.8) 93.4(7.2) 88.3(7.2) 88.1(5.5) 92.4(6.2)
0.15Cauchy Unrobust 78.4(10.5) 83.1(11.4) 84.8(8.2) 75.5(10.8) 83.0(12.5)
Stute 65.8(7.0) 72.2(6.2) 67.5(6.7) 61.2(5.1) 70.4(7.3)
Quantile 82.1(3.1) 85.7(1.9) 92.5(2.3) 87.6(3.1) 69.3(5.8)
0.7N(0,1)+ Robust 88.0(7.4) 87.5(7.5) 90.7(5.5) 92.8(6.1) 82.7(6.4)
0.3Cauchy Unrobust 72.7(10.4) 74.4(14) 89.3(7.5) 92.5(8.9) 74.4(10.5)
Stute 58.2(6.2) 64.9(7.8) 68.6(5.0) 63.0(4.9) 62.4(6.6)
Quantile 82.3(2.6) 86.3(2.7) 92.4(3.1) 88.6(2.1) 70.6(3.4)
0.95N(0,1)+ Robust 73.4(5.8) 87.7(6.5) 92.5(5.1) 78.8(5.6) 90.6(6.3)
0.05t(3) Unrobust 78.9(7.5) 85.8(9.9) 87.6(10.0) 80.7(9.4) 89.0(8.4)
Stute 66.2(4.8) 68.9(5.5) 68.6(5.0) 68.3(5.1) 68.9(4.2)
Quantile 80.4(3.1) 83.1(4.1) 89.9(2.4) 86.6(4.1) 69.4(7.0)
0.85N(0,1)+ Robust 83.0(7.5) 84.7(8.2) 82.6(5.8) 79.4(7.0) 86.4(6.2)
0.15t(3) Unrobust 74.5(9.8) 76.6(11.2) 74.7(12.5) 76.4(13.6) 77.5(10.0)
Stute 57.2(5.3) 64.6(6.2) 68.6(5.0) 67.6(5.4) 65.8(6.1)
Quantile 81.6(3.8) 83.9(3.3) 82.3(2.4) 86.6(2.2) 69.1(4.9)
0.7N(0,1)+ Robust 85.2(7.3) 90.0(6.7) 85.8(5.6) 94.8(5.3) 81.5(5.9)
0.3t(3) Unrobust 75.6(11.4) 75.2(10.3) 81.8(6.4) 83.0(5.3) 74.7(11.3)
Stute 57.2(6.2) 64.8(6.6) 68.6(5.0) 63.3(7.4) 62.0(5.9)
Quantile 79.7(2.7) 83.6(1.6) 91.9(2.3) 87.9(1.9) 68.3(6.1)
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Table 3: Analysis of the lung cancer data using the robust method: estimates ×100. For the interactions, values in “()” are the
stability results.
Main effects Interactions
age gender intensity status gene age gender intensity status
AP1S2 -1.0 -22.6 -0.1 37.4 20.8 -0.2(0.998)
BTD 0.8 -8.6 0.2 5.1 -56.7 15.9(1.000)
C10ORF54 0.7 2.7 0.2 6.2 3.2 -0.5(0.998)
CA5BP1 -1.2 -6.3 0.1 29.0 7.5 14.8(1.000)
CAPN1 -3.5 -8.9 0.3 -8.6 -50.0 -24.7(0.000)
CEBPB -1.0 -15.5 0.0 29.4 -41.6 8.1(0.998)
EFNA1 -0.7 5.9 1.0 4.0 -65.3 12.7(1.000)
FAM107B -1.2 -19.3 -0.1 16.2 29.2 -0.8(1.000)
FLRT3 -1.2 24.6 0.8 6.1 33.4 -1.5(0.998)
KATNB1 -0.0 0.5 0.2 26.6 -76.2 39.8(0.995) 30.6(0.059)
LRRC1 -3.6 -13.6 -0.3 64.5 25.5 -24.3(0.995)
LYRM5 0.8 -10.2 0.1 4.4 -12.0 -6.8(1.000)
AP1S2.1 -1.0 -22.6 -0.1 37.4 20.8 -0.2(0.998)
MYO18A 1.5 -15.9 0.1 -7.8 16.3 0.2(1.000)
NOD1 -1.3 16.0 -0.1 4.6 -28.9 -0.3(0.998)
NPLOC4 -3.3 -34.8 0.7 58.4 -76.3 14.4(0.998)
PLEKHO2 0.2 11.2 0.1 1.1 -15.3 -0.5(0.998)
POLR3GL -4.3 -1.7 0.0 63.0 28.2 0.1(0.998)
RAB27A 0.6 -12.9 0.0 10.1 14.4 -0.5(0.998)
SECISBP2L -3.7 -34.7 -0.5 55.3 30.4 -0.8(0.998)
SGTB 2.0 -17.5 0.2 3.3 7.4 0.2(0.995)
STRADB -0.7 -3.4 0.1 4.1 1.2 -48.5(0.995)
SWSAP1 1.9 -14.6 0.1 -2.9 -12.1 0.8(0.995)
TEP1 1.7 -33.3 0.3 -0.9 5.4 0.3(1.000)
TERF1 0.2 -22.0 -0.0 43.2 46.4 -18.9(1.000)
THOC1 0.9 30.9 1.2 -0.8 31.4 -67.4(0.002)
TIGD5 1.5 -11.6 1.1 -32.5 3.9 -10.4(1.000)
TK2 -1.0 -13.8 -0.4 25.0 24.7 -0.8(1.000)
TMEM54 3.7 -40.0 0.5 -33.2 -6.1 -69.2(1.000)
TMEM106A -0.8 -11.2 0.2 20.4 4.1 -0.3(0.998)
TOMM7 1.8 0.1 0.1 -7.7 -21.4 2.3(0.998)
TRIM34 0.4 5.5 0.2 2.1 -13.4 -0.3(0.998)
YARS2 0.5 8.1 0.9 -9.7 -5.8 -2.5(0.998)
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Figure 1: An illustration of the ROC curves for the proposed and alternative methods.
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Appendix
Consistency properties
Here we rigorously prove that the proposed method can consistently identify the important interac-
tions under ultrahigh-dimensional settings. With the consistency properties, the proposed method
can be preferred over the alternatives whose statistical properties have not been well established.
First we show that, under mild conditions, the proposed method can distinguish the important
effects from unimportant ones in the presence of censoring. For each j ∈ {1, 2, · · · , p}, define the
population version of the marginal estimate as
ζMj = argmaxζjE{exp(−(T −U⊤j ζj)2/θ)},
where E denotes expectation under the true model. Denote the kth element of ζj by ζj,k. The
corresponding important covariate effect index set in ζMj is labeled as Sj = {k ∈ {1, . . . , 2q + 2} :
ζMj,k 6= 0}. Denote AX = ∪pj=1{t : t ∈ Sj, 2 ≤ t ≤ q+1} as the important set with its corresponding
environmental variables important in at least one marginal model. If q+2 ∈ Sj, then the jth gene
is associated with the disease outcome in a marginal sense. The set {t : t ∈ Sj, q + 3 ≤ t ≤ 2q + 2}
contains important interactions between the jth gene and environmental variables. Then we have
the important gene set AG = ∪pj=1{j : q+2 ∈ Sj} and interaction set AI = ∪pj=1{(j−1)p+t−q−2 :
t ∈ Sj, q+3 ≤ t ≤ 2q+2}. Denote Sc and |S| as the complement and cardinality of set S respectively.
Denote the kth element of ui,j by u(i,j)k , k = 1, . . . , 2q + 2.
For each j ∈ {1, 2, · · · , p}, define
Dn(ζj) =
n∑
i=1
ωi exp(−(yi − u⊤i,jζj)2/θ)
2(yi − u⊤i,jζj)
θ
ui,j
and
In(ζj) =
2
θ
n∑
i=1
ωi exp(−(yi − u⊤i,jζj)2/θ)
(
2(yi − u⊤i,jζj)2
θ
− 1
)
ui,ju
⊤
i,j.
Let τY , τT and τC be the end points of the support of Y, T and C, respectively. Assume the following
regularity conditions:
C1. The observations {(yi, δi,xi, zi), 1 ≤ i ≤ n} are independent and identically distributed;
C2. T and C are independent and P (T ≤ C|T,X,Z) = P (T ≤ C|T );
C3. τT < τC or τT = τC =∞;
C4. q is a fixed. For each j ∈ {1, 2, · · · , p}, √nDn(ζMj ) →d N(0,Σj), where Σj is a positive
definite matrix. In(ζ
M
j ) converges to some negative definite matrix I(ζ
M
j ) in probability.
Moreover, the smallest eigenvalue ρ∗ = minj ρmin(−I(ζMj )) and the largest eigenvalue ρ∗ =
maxj ρmax(Σj) are bound away from zero and infinity.
C5. Let Nj denote a sufficient small neighborhood centered at ζ
M
j . For ζ
1
j , ζ
2
j ∈ Nj , there exists
a bounded constant V such that ζ⊤j [I(ζ
1
j )−I(ζ2j )]ζj ≤ V ‖ζ1j −ζ2j ‖2 with any ‖ζj‖2 = 1. More-
1
over, For any k1, k2 ∈ {1, . . . , 2q+2}, E(exp(−(yi−u⊤i,jζ∗j )2/θ)
(
2(yi−u
⊤
i,jζ
∗
j )
2
θ
− 1
)
u(i,j)k1
u(i,j)k2
)2 ≤
J , where J is finite and ζ∗j ∈ Nj .
Remark 1. C1-C3 have been commonly assumed in models with random censoring. Condition
C4 is mild and has been proved under some regular conditions in Stute (1993) and Huang et al.
(2007). C5 is added to simplify the proof.
If the truly important effects were known, then we would be able to compute the oracle esti-
mator. Consider the oracle estimation ζˆj with ζˆScj = 0 and
ζˆSj = argmax
n∑
i=1
ωi exp(−(yi − u⊤(i,j)Sj ζj,Sj)
2/θ)− λ
∑
k∈Sj
|ζj,k|. (7)
Theorem 1. Consider the estimator defined in (7). Under Condition C1-C5 and 6(n−κ+12ρ−1∗ (q+
1)λ)V < ρ∗, we have
Pr
(
max
1≤j≤p
max
s∈Sj
|ζˆj,s − ζMj,s| ≥ n−κ + 12qρ−1∗ λ
)
≤ p exp
(
−ρ
2
∗n
1−2κ + 144q2nλ2
36ρ∗
)
+ 4p(q + 1) exp
(
− nρ
2
∗
36J(q + 1)2
)
,
where κ < 1/2.
The tail probability in Theorem 1 is exponentially small. In other words, the proposed method
is able to accommodate ultrahigh dimensional data with
log p = o(n1−2κ + nλ2).
Recall that ζ˜j = argmaxζ∈R2q+2L(ζj), where
L(ζj) =
n∑
i=1
ωi exp(−(yi − u⊤i,jζj)2/θ)− λ||ζj ||1. (8)
Since L(ζj) in (8) is concave, if we can show the oracle estimator ζˆj satisfies the Karush-Kuhn-
Tucher(KKT) condition, then ζ˜j = ζˆj .
Define A˜G = ∪pj=1{j : ζ˜j,q+2 6= 0} and A˜I = ∪pj=1{(j−1)p+t−q−2 : ζ˜j,t 6= 0, q+3 ≤ t ≤ 2q+2}.
Partition I(ζMj ) according to Sj as
I(ζMj ) =
(
ISjSj (ζ
M
j ) ISjSjc(ζ
M
j )
ISjcSj (ζ
M
j ) ISjcSjc(ζ
M
j )
)
.
The following theorem establishes that the proposed method has the asymptotic consistency prop-
erties.
Theorem 2. Assume Condition C1-C4, κ < 1/2 and Φj = ‖ISjcSj(ζMj )ISjSj (ζMj )−1‖∞ ≤ K < 1.
2
If OG ⊆ AG and OI ⊆ AI , we have
Pr
(
OG ⊆ A˜G and OI ⊆ A˜I
)
≥ 1−O
(
p exp
(
−ρ
2
∗n
1−2κ + 144q2nλ2
36ρ∗
)
+ p exp
(
−nλ
2(1−K)2
2ρ∗(1 +K)2
))
.
Below we provide proofs for the two theorems.
Proof of Theorem 1
Recall that
ζˆj,Sj = argmax
n∑
i=1
ωi exp(−(yi − u⊤(i,j)Sj ζj,Sj)
2/θ)− λ
∑
k∈Sj
|ζj,k|. (9)
Denote the above objective function as Rn(ζj,Sj).
First, let rj = n
−κ + 12ρ−1∗ (q + 1)λ and η =
p∑
j=1
exp
(
−ρ2∗n1−2κ+144(q+1)2n−1λ236ρ∗
)
, where κ < 1/2.
To prove that
Pr
{
‖ζj,Sj − ζMj,Sj‖2 < rj, j = 1, · · · , p
}
≥ 1− η,
it suffices to show that
Pr
(
sup
ζj,Sj∈I
Rn(ζj,Sj ) < Rn(ζ
M
j,Sj
), j = 1, · · · , p
)
≥ 1− η, (10)
where I =
{
ζj,Sj : ‖ζj,Sj − ζMj,Sj‖2 = rj , j = 1, · · · , p
}
. This implies that with probability at least
1− η, Rn(ζj,Sj) has a global maximizer ζˆj,Sj that satisfies ‖ζj,Sj − ζMj,Sj‖2 < rj , for j = 1, · · · , p.
Recall the definitions of Dn(ζj) and In(ζj). Partition them according to Sj as
Dn(ζj) =
(
Dn,Sj (ζj)
Dn,Scj (ζj)
)
, In(ζj) =
(
In,SjSj(ζj) In,SjScj (ζj)
In,ScjSj (ζj) In,ScjScj (ζj)
)
.
Obviously,
Dn,Sj (ζj) =
n∑
i=1
ωi exp(−(yi − u⊤(i,j)Sj ζj,Sj)
2/θ)
2(yi − u⊤(i,j)Sj ζj,Sj)
θ
u(i,j)Sj
and
In,SjSj(ζj) =
2
θ
n∑
i=1
ωi exp(−(yi − u⊤(i,j)Sj ζj,Sj)
2/θ)
2(yi − u⊤(i,j)Sj ζj,Sj)2
θ
− 1
u(i,j)Sju⊤(i,j)Sj .
In fact, by Taylor’s expansion we have
Rn(ζj,Sj)−Rn(ζMj,Sj)
=
n∑
i=1
ωi
{
exp(−(yi − u⊤(i,j)Sj ζj,Sj)
2/θ)− exp(−(yi − u⊤(i,j)Sj ζ
M
j,Sj
)2/θ)
}
3
−λ
∑
k∈Sj
(|ζj,k| − |ζMj,k|}
= Dn,Sj(ζ
M
j )
⊤(ζj,Sj − ζMj,Sj) +
1
2
(ζj,Sj − ζMj,Sj)⊤In,SjSj (ζ¯j)(ζj,Sj − ζMj,Sj)
+λ
∑
k∈Sj
(|ζMj,k| − |ζj,k|} , (11)
where ζ¯j lies between ζ
M
j and ζj .
It is easy to see that
(ζj,Sj − ζMj,Sj)⊤In,SjSj (ζ¯j)(ζj,Sj − ζMj,Sj)
= (ζj,Sj − ζMj,Sj)⊤ISjSj(ζMj )(ζj,Sj − ζMj,Sj)
+(ζj,Sj − ζMj,Sj)⊤
{
ISjSj (ζ¯j)− ISjSj (ζMj )
}
(ζj,Sj − ζMj,Sj)
+(ζj,Sj − ζMj,Sj)⊤
{
In,SjSj(ζ¯j)− ISjSj (ζ¯j)
}
(ζj,Sj − ζMj,Sj)
= Q1 +Q2 +Q3. (12)
By C4, Q1 ≤ −‖ζj,Sj − ζMj,Sj‖22ρ∗. Moreover, Q2 ≤ V ‖ζj,Sj − ζMj,Sj‖32 under C5. Bernstein inequality
and C5 yield
Pr(‖In,SjSj (ζ¯j)− ISjSj(ζ¯j)‖2F ≥
ρ2∗
9
) ≤ 2|Sj | exp
(
− nρ
2
∗
9J |Sj |2
)
,
where ‖ · ‖F denotes the Frobenius norm. Since λmax(In,SjSj(ζ¯j) − ISjSj (ζ¯j)) ≤ ‖In,SjSj (ζ¯j) −
ISjSj (ζ¯j)‖F , we have Q3 ≤ 13ρ∗r2j . Therefore, the second term in (11) can be controlled by
1
2
(ζj,Sj − ζMj,Sj)⊤In,SjSj (ζMj )(ζj,Sj − ζMj,Sj) < −
1
3
ρ∗r
2
j +
1
2
V r3j , (13)
with probability at least 1− 4(q + 1) exp
(
− nρ2∗36J(q+1)2
)
due to (12) and |Sj| ≤ 2q + 2.
Partition Σj according to Sj as
(
ΣSjSj ΣSjScj
ΣSc
j
Sj ΣScjScj
)
. For Dn,Sj(ζ
M
j ), by the definition of ζ
M
j,Sj
,
and conditions C2 and C4, we have
√
nDn,Sj(ζ
M
j )→d N(0,ΣSjSj ).
Then for any given t, an application of Bernstein’s inequality,
Pr(|Dn,Sj (ζMj )⊤(ζj,Sj − ζMj,Sj)| > t) ≤ 2 exp
(
− nt
2
2(ζj,Sj − ζMj,Sj)⊤ΣSjSj (ζj,Sj − ζMj,Sj)
)
.
Recall that rj = n
−κ + 12ρ−1∗ (q + 1)λ. Let t =
1
6ρ∗r
2
j , then we have
Pr(Dn,Sj (ζ
M
j )
⊤(ζj,Sj − ζMj,Sj) >
1
6
ρ∗r
2
j ) ≤ exp
(
−ρ
2
∗n
1−2κ + 144(q + 1)2nλ2
36ρ∗
)
. (14)
4
By the Triangle inequality and (
d∑
i=1
|vi|)2 ≤ d
d∑
i=1
v2i for any sequence vi, we have
λ
∑
k∈Sj
(|ζMj,k| − |ζj,k|} ≤ λ∑
k∈Sj
|ζMj,k − ζj,k| ≤ λ
√
|Sj |‖ζj,Sj − ζMj,Sj‖2. (15)
Combining (11), (13), (14),(15), and 6(n−κ + 12ρ−1∗ (q + 1)λ)V < ρ∗, we have
Rn(ζj,Sj)−Rn(ζMj,Sj) < −
1
6
ρ∗r
2
j + λ
√
|Sj |rj + 1
2
V r3j < 0 (16)
with probability at least 1 − exp
(
−ρ2∗n1−2κ+144(q+1)2nλ236ρ∗
)
− 4(q + 1) exp
(
− nρ2∗
36J(q+1)2
)
. Together
with the Bonferroni’s inequality, we have the conclusion. 
Proof of Theorem 2
Recall that ζ˜j = argmaxζ∈R2q+2L(ζj), where
L(ζj) =
n∑
i=1
ωi exp(−(yi − u⊤i,jζj)2/θ)− λ||ζj ||1. (17)
Consider the oracle estimation ζˆj with ζˆScj = 0 and
ζˆj,Sj = argmax
n∑
i=1
ωi exp(−(yi − u⊤(i,j)Sj ζj,Sj)
2/θ)− λ
∑
k∈Sj
|ζj,k|. (18)
Denote the above objective function as Rn,Sj(ζj). Since L(ζj) in (8) is concave, if we can show that
the oracle estimation ζˆj satisfies Karush-Kuhn-Tucher(KKT) condition, then ζ˜j = ζˆj . Hereafter
we will focus on proving that the oracle estimation ζˆj satisfies KKT condition.
Next we want to show that ∣∣Ωn(Scj )∣∣∞ < λ, j = 1, 2, · · · , p (19)
where |ν|∞ = maxi |νi| for any vector ν = (ν1, · · · , ν|Scj |) and
Ωn(S
c
j ) =
n∑
i=1
ωi exp(−
(yi − u⊤(i,j)Sj ζˆj,Sj)
2
θ
)
2(yi − u⊤(i,j)Sj ζˆj,Sj)
θ
u(i,j)Sc
j
.
Applying Taylor’s expansion, we have
Ωn(S
c
j ) =
n∑
i=1
ωi exp
−(yi − u
⊤
(i,j)Sj
ζMj,Sj)
2
θ
 2(yi − u
⊤
(i,j)Sj
ζMj,Sj)
θ
u(i,j)Sc
j
+
2
θ
n∑
i=1
ωi exp
−(yi − u
⊤
(i,j)Sj
ζ¯j,Sj)
2
θ

2(yi − u⊤(i,j)Sj ζ¯j,Sj)2
θ
− 1

5
× u(i,j)Sc
j
u⊤(i,j)Sj
(ζˆj,Sj − ζMj,Sj)
:= Γn +∆n, (20)
where ζ¯j lies between ζ
M
j and ζˆj . From the proof of Theorem 1, we have
ζˆj,Sj − ζMj,Sj = In,SjSj(ζMj )−1{−Dn,Sj(ζMj ) + λsgn(ζMj )}. (21)
Hence substituting (21) into (20), we obtain
∆n =
2
θ
n∑
i=1
ωi exp
−(yi − u
⊤
(i,j)Sj
ζ¯j,Sj)
2
θ

2(yi − u⊤(i,j)Sj ζ¯j,Sj)2
θ
− 1

× u(i,j)Sc
j
u⊤(i,j)Sj
In,Sj(ζ
M
j )
−1{−Dn,Sj (ζMj ) + λsgn(ζMj )}
= −In,SjcSj(ζ¯j)In,SjSj(ζMj )−1Dn,Sj(ζMj ) + λIn,SjcSj(ζ¯j)In,Sj (ζMj )−1sgn(ζMj ). (22)
Next we define
∆∗n = −ISjcSj (ζMj )ISjSj(ζMj )−1Dn,Sj (ζMj ) + λISjcSj(ζMj )ISjSj (ζMj )−1sgn(ζMj ),
and Ω∗n(S
c
j ) = Γn + ∆
∗
n. From the proof of Theorem 1, we find the tail probability for In(ζj) is
dominated by that for Dn(ζj). Thus
Pr(
∣∣Ωn(Scj )∣∣∞ > λ) ≍ Pr(∣∣Ω∗n(Scj )∣∣∞ > λ).
Therefore, combining the above discussion, we only need focus on Ω∗n(S
c
j ). In fact,
|Ω∗n(Scj )|∞ ≤ |Γn|∞ + |∆∗n|∞
≤ |Dn,Scj (ζMj )|∞ + |ISjcSj(ζMj )ISjSj (ζMj )−1Dn,Sj(ζMj )|∞
+ λ|ISjcSj(ζMj )ISjSj (ζMj )−1Dn,Sj(ζMj )sgn(ζMj )|∞
≤ |Dn(ζMj )|∞ + ‖ISjcSj(ζMj )ISjSj (ζMj )−1‖∞|Dn(ζMj )|∞ + λ‖ISjcSj(ζMj )ISjSj (ζMj )−1‖∞(23)
By the condition Φj = ‖ISjcSj(ζMj )ISjSj (ζMj )−1‖∞ ≤ K < 1, if
|D∗n(ζMj )|∞ < λ
1− Φj
1 + Φj
, (24)
then from (23), it follows
|Ω∗n(Scj )|∞ ≤ |Dn(ζMj )|∞(1 + Φj) + λΦj
< λ(1− Φj) + λΦj = λ,
which proves (19). We now derive the probability bounds for the event in (24). Similarly as the
6
derivation of (14),
Pr
{
|Dn(ζMj )|∞ ≥ λ
1− Φj
1 + Φj
}
≤ 2 exp
(
−nλ
2(1− Φj)2
2ρ∗(1 + Φj)2
)
. (25)
By the Bonferroni’s inequality, we obtain
Pr
{
|Dn(ζMj )|∞ < λ
1− Φj
1 + Φj
, j = 1, 2, · · · , p
}
≥ 1− 2
p∑
j=1
exp
(
−nλ
2(1− Φj)2
2ρ∗(1 + Φj)2
)
. (26)
Based on the above result, the theorem is proved. 
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Additional numerical results
Table 4: Summary analysis results for the lung cancer data using different methods. Diagonals
are the numbers of identified genes using different methods. Off-diagonals are the numbers of
overlapping genes. In “()” are the numbers of overlapping interactions.
Robust Unrobust Stute Quantile
Robust 33 9(5) 0(0) 0(0)
Unrobust - 31 3(0) 1(0)
Stute - - 30 2(1)
quantile - - - 28
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Table 5: Analysis of the lung cancer data using the unrobust method: estimates ×100.
Main effect Interaction
age gender intensity status gene age gender intensity status
BCL10 5.5 79.8 0.3 105.6 10.3 -29.2
BTD 6.1 38.4 0.9 91.5 -187.4 94.8
CAPN1 6.1 77.3 -0.0 97.9 22.1 -36.2
CASK 6.4 59.1 0.4 81.9 90.5 -63.1
CSNK1G2 5.9 31.0 0.5 98.0 -20.5 -70.4
DOCK6 5.7 100.0 0.4 85.6 6.5 -35.4
ECI2 7.3 42.0 1.1 39.6 -87.0 57.3
ELMO3 5.1 88.5 0.1 122.5 -34.5 -12.1
FAM83H 5.6 57.3 0.5 116.1 113.1 -72.0
FASN 6.0 53.2 0.7 93.0 117.7 -78.4
KATNB1 6.2 59.6 0.4 85.0 55.6 -49.1
LYRM5 7.4 35.4 0.9 40.4 -43.4 12.2 32.8
MACROD1 5.8 73.2 0.3 99.1 73.1 -58.4
NACC2 6.1 65.9 0.3 92.6 100.7 -70.9
PKP3 5.8 73.9 0.1 99.0 43.3 -54.8
RBFA 5.8 62.4 0.1 104.4 10.9 -66.1
RNH1 6.0 70.6 0.5 79.8 14.9 -32.7
SCYL1 5.5 84.1 0.4 105.6 -36.2 -6.3
STRADB 6.1 59.7 0.9 76.1 -108.6 62.6
SWSAP1 5.8 69.7 0.4 92.9 18.0 -30.6
TEN1 5.6 66.3 0.6 104.1 21.9 -34.3
TIGD5 5.5 46.3 0.8 113.7 125.3 -73.9
TMEM54 6.1 54.6 -0.0 101.4 -1.3 -81.0
TNIP2 5.1 85.9 0.6 100.9 -50.6 -4.2
TOLLIP 6.3 68.2 0.5 73.2 39.8 -48.4
TTC22 5.6 72.3 0.1 114.0 -20.3 -51.8
WASH2P 5.7 25.2 0.3 109.1 19.9 -129.7
YARS2 8.1 18.8 1.1 13.9 -41.6 26.5
YIPF2 5.7 75.2 0.4 99.8 7.8 -27.4
ZNF512B 6.3 54.7 0.4 89.8 94.9 -45.3 -49.6
ZNF699 5.8 93.7 0.5 86.0 59.1 -56.4
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Table 6: Analysis of the lung cancer data using the Stute method: estimates ×100.
Main effects Interactions
age gender intensity status gene age gender intensity status
KLHL9 8.1 17.9 1.0 29.2 -358.5 5.4
TPD52L2 7.5 56.8 1.0 31.2 313.5 -4.7
TMEM129 7.7 21.9 1.1 28.5 -522.3 7.4
PCGF3 8.2 20.2 1.1 15.9 -527.4 7.6
XPNPEP1 7.8 30.0 0.9 26.1 -544.6 7.9
FDPS 7.6 24.8 1.1 37.0 254.2 -3.8
GFOD2 7.3 24.7 1.0 40.8 -447.1 6.1
MAGED4B 7.3 23.3 1.0 44.8 -654.5 9.2
PIGG 8.0 11.6 1.0 27.6 -354.2 5.1
UVSSA 8.3 21.3 1.0 17.1 -527.7 7.7
LAMTOR2 7.4 37.0 1.0 36.8 263.9 -3.7
CSNK1G2 7.2 26.4 0.9 44.5 -390.9 5.2
POLR3C 7.7 24.1 1.2 26.7 230.6 -3.3
CTBP1 7.9 17.1 1.1 24.4 -361.4 5.2
PRUNE 7.6 26.2 1.1 33.6 258.6 -3.7
NELFA 7.6 28.8 1.0 32.4 -464.8 6.6
MAEA 7.8 14.9 1.0 33.5 -418.3 6.0
RPS27A 7.7 33.9 1.0 27.1 401.0 -5.8
TBC1D14 7.6 21.4 0.9 34.0 -510.9 7.2
MAN2B2 7.7 27.7 1.1 21.9 -481.9 6.8
DGKQ 7.3 31.0 1.1 36.0 -552.6 7.7
RBFA 7.6 -0.7 0.9 39.7 -565.2 7.8
ACOX3 7.7 19.0 1.2 20.3 -595.1 8.2
TCF25 7.6 27.0 1.1 33.5 -578.8 8.5
PIGC 7.6 27.7 1.1 32.6 190.4 -2.7
TOLLIP 7.2 25.6 1.0 38.7 -393.2 4.9
CREG1 7.4 28.9 1.0 44.0 198.6 -2.9
RAB11B 7.1 30.2 1.1 46.4 -342.1 4.7
CDKN2AIP 7.8 40.2 0.9 32.3 -576.4 8.5
GAK 7.9 31.3 1.1 19.4 -452.0 6.5
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Table 7: Analysis of the lung cancer data using the quantile method: estimates ×100.
Main effects Interactions
age gender intensity status gene age gender intensity status
ARHGAP1 8.0 -18.2 0.8 16.1 -338.5 5.1
B3GALT4 7.9 -8.1 1.2 14.1 -58.9 1.5
BCL11A 8.1 -12.8 0.8 16.3 9.8
CDKN1A 8.1 -5.3 0.7 16.9 -193.6 2.5
CHIC2 8.3 -0.3 0.9 -1.0 -530.8 7.8 127.8
CHST10 8.1 -7.3 0.8 16.6 18.9
DNM2 8.0 -5.0 0.9 13.5 -245.4 3.4
FAM65A 7.8 5.0 0.8 18.5 -220.7 2.7
GATAD1 8.1 -4.2 0.9 11.8 -42.0 19.6
GGT5 8.2 -14.7 0.8 14.2 -152.4 1.7
GRB7 8.0 -5.1 0.6 24.0 -1.1 66.4
HIST1H4D 8.0 -13.5 0.9 16.7 13.0
LAS1L 7.8 -2.1 0.8 22.9 -12.8
LETM1 7.8 -3.4 1.1 15.6 -54.2 1.1
MAEA 7.8 -3.5 1.2 13.2 -36.1 0.6
PAPOLG 8.0 -16.6 0.8 12.5 16.0
PDGFA 7.9 2.5 0.8 23.1 -240.6 3.5
PDGFRA 8.0 5.7 0.6 21.1 -384.8 4.9 83.9
PPARD 8.1 -5.6 0.8 13.7 -270.3 3.8
PTAFR 8.2 -7.0 0.8 11.6 -258.1 3.7
RXRB 7.8 -5.2 1.4 7.1 -71.6 1.3
SCARNA9 8.1 -9.5 0.7 16.7 23.7
SLC12A4 8.0 -11.2 0.8 18.3 -224.0 2.7
TMEM204 8.1 -2.0 0.8 11.5 -317.9 4.2
TOLLIP 8.0 -6.3 0.9 11.7 -336.9 4.8
TOMM5 8.0 -6.9 0.8 17.8 25.2
ZNF141 7.5 24.8 1.4 8.0 -105.4 65.8 1.3
ZNF761 8.0 -19.2 1.0 17.0 -37.4 83.0
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